Opioid-refractory chronic cancer-related pain

Clinical trials for Opioid-refractory chronic cancer-related pain explained in plain language.

Never miss a new study

Get alerted when new Opioid-refractory chronic cancer-related pain trials appear

Sign up with your email to follow new studies for Opioid-refractory chronic cancer-related pain, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New combo infusion aims to tame Opioid-Resistant cancer pain

Symptom relief Recruiting now

This early-phase trial tests whether combining lidocaine and ketamine can reduce severe cancer-related pain that doesn't respond to opioids. Twenty-four adults will receive two weekly infusions of the drug combination or an active placebo in a blinded, crossover design. The goal …

Matched conditions: OPIOID-REFRACTORY CHRONIC CANCER-RELATED PAIN

Early phase 1 • Sponsor: National and Kapodistrian University of Athens • Aim: Symptom relief

Last updated Jul 09, 2026 00:00 UTC

Opioid-refractory chronic cancer-related pain

Get alerted when new Opioid-refractory chronic cancer-related pain trials appear

New combo infusion aims to tame Opioid-Resistant cancer pain